239 related articles for article (PubMed ID: 17507800)
1. Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells.
Mei YP; Zhou JM; Wang Y; Huang H; Deng R; Feng GK; Zeng YX; Zhu XF
Cell Cycle; 2007 Jun; 6(11):1379-85. PubMed ID: 17507800
[TBL] [Abstract][Full Text] [Related]
2. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
[TBL] [Abstract][Full Text] [Related]
3. Latent membrane protein-1 of Epstein-Barr virus inhibits cell growth and induces sensitivity to cisplatin in nasopharyngeal carcinoma cells.
Liu Y; Wang X; Lo AK; Wong YC; Cheung AL; Tsao SW
J Med Virol; 2002 Jan; 66(1):63-9. PubMed ID: 11748660
[TBL] [Abstract][Full Text] [Related]
4. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
Zheng H; Li LL; Hu DS; Deng XY; Cao Y
Cell Mol Immunol; 2007 Jun; 4(3):185-96. PubMed ID: 17601372
[TBL] [Abstract][Full Text] [Related]
5. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma.
Horikawa T; Yang J; Kondo S; Yoshizaki T; Joab I; Furukawa M; Pagano JS
Cancer Res; 2007 Mar; 67(5):1970-8. PubMed ID: 17332324
[TBL] [Abstract][Full Text] [Related]
6. Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells.
Sung WW; Chu YC; Chen PR; Liao MH; Lee JW
Cancer Lett; 2016 Nov; 382(1):21-31. PubMed ID: 27567526
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
[TBL] [Abstract][Full Text] [Related]
8. Effect of inhibition of EBV-encoded latent membrane protein-1 by small interfering RNA on EBV-positive nasopharyngeal carcinoma cell growth.
Li G; Li XP; Peng Y; Liu X; Li XH
Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):241-6. PubMed ID: 15041532
[TBL] [Abstract][Full Text] [Related]
9. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
[TBL] [Abstract][Full Text] [Related]
10. Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway.
Li SS; Yang S; Wang S; Yang XM; Tang QL; Wang SH
Oncol Rep; 2011 Dec; 26(6):1573-9. PubMed ID: 21850380
[TBL] [Abstract][Full Text] [Related]
11. Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes.
Li B; Wan Z; Huang G; Huang Z; Zhang X; Liao D; Luo S; He Z
BMC Cancer; 2015 May; 15():390. PubMed ID: 25958199
[TBL] [Abstract][Full Text] [Related]
12. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
[TBL] [Abstract][Full Text] [Related]
13. EBV-encoded LMP-1 sensitizes nasopharyngeal carcinoma cells to genotoxic drugs by down-regulating Cabin1 expression.
Chang PY; Wu ZZ; Sun NK; Chao CC
J Cell Physiol; 2014 Mar; 229(3):309-22. PubMed ID: 23939952
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells.
Lo AK; Huang DP; Lo KW; Chui YL; Li HM; Pang JC; Tsao SW
Int J Cancer; 2004 May; 109(6):919-25. PubMed ID: 15027126
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.
Yang GD; Huang TJ; Peng LX; Yang CF; Liu RY; Huang HB; Chu QQ; Yang HJ; Huang JL; Zhu ZY; Qian CN; Huang BJ
PLoS One; 2013; 8(10):e78355. PubMed ID: 24194922
[TBL] [Abstract][Full Text] [Related]
17. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
18. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
[TBL] [Abstract][Full Text] [Related]
19. Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-κB axis during nasopharyngeal carcinoma development.
Liu Y; Gong P; Zhou N; Zhang J; He C; Wang S; Peng H
Biochem Biophys Res Commun; 2019 Jun; 514(1):127-133. PubMed ID: 31027734
[TBL] [Abstract][Full Text] [Related]
20. Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance.
Xie L; Shi F; Li Y; Li W; Yu X; Zhao L; Zhou M; Hu J; Luo X; Tang M; Fan J; Zhou J; Gao Q; Wu W; Zhang X; Liao W; Bode AM; Cao Y
Signal Transduct Target Ther; 2020 May; 5(1):56. PubMed ID: 32433544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]